Will Biotechnology Companies Lose Ability to Restrict Production of Their Self-Replicating Products?; Merck Did Reveal Its Process and Is Not Guilty of Fraud; BLR Archives: AstraZeneca Coverage of Cardiovascular Drug Falls for Double Patenting

摘要

omputer industry that is now before the SupremenCourt is exercising biotechnology companies.nQuanta Computer, Inc. et al. v. LG Electronics, Inc.net al. (No. 06-937) is a question of patent exhaustionn(first sale): “Whether patent rights are exhausted by anlicensee’s authorized sale of a patented product to annauthorized purchaser, where that product has no reasonablenuse other than in practicing the patented invention.”